# Eli Lilly and Company: what changed between 2025-11-08 and 2026-11-08 entity: /record/eli-lilly.md from: 2025-11-08 to: 2026-11-08 page: /record/eli-lilly/diff?from=2025-11-08&to=2026-11-08 json: /v1/entities/eli-lilly/diff?from=2025-11-08&to=2026-11-08 Between 2025-11-08 and 2026-11-08, Eli Lilly and Company's record changed in 14 facts: 2 replaced (net income $10.59 billion → $20.64 billion; revenue $45.04 billion → $65.18 billion), 6 added, 6 ended; 10 unchanged. State as of 2025-11-08: /record/eli-lilly.md?as_of=2025-11-08 · as of 2026-11-08: /record/eli-lilly.md?as_of=2026-11-08. Format: subject | predicate | value | valid range | confidence | status | claim. Posts and Hugging Face repos are left out (0 held on 2025-11-08, 0 on 2026-11-08). ## Replaced (2) The same fact with a different value: the claim that held on the earlier day, then the one that holds on the later day. - net income: $10.59 billion → $20.64 billion - [Eli Lilly and Company](/record/eli-lilly.md) | net_income | 10,590,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_DBEC55E24C06](/claim/clm_DBEC55E24C06.md) | [clm_2BC21A73296C](/claim/clm_2BC21A73296C.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/0000059478-25-000067-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | net_income | 20,640,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_DBEC55E24C06](/claim/clm_DBEC55E24C06.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/0000059478-26-000013-index.htm - revenue: $45.04 billion → $65.18 billion - [Eli Lilly and Company](/record/eli-lilly.md) | revenue | 45,042,700,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_C4636B99C62B](/claim/clm_C4636B99C62B.md) | [clm_282E1F71B318](/claim/clm_282E1F71B318.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/0000059478-25-000067-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | revenue | 65,179,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_C4636B99C62B](/claim/clm_C4636B99C62B.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/0000059478-26-000013-index.htm ## Added (6) Held on 2026-11-08, not on 2025-11-08. - [Eli Lilly and Company](/record/eli-lilly.md) | cash_and_equivalents | 4,885,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_BC1171A7B218](/claim/clm_BC1171A7B218.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/0000059478-26-000108-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 6,451,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_9D57FD94603E](/claim/clm_9D57FD94603E.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/0000059478-26-000108-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_revenue | 24,397,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_E1B01E0405B5](/claim/clm_E1B01E0405B5.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/0000059478-26-000108-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | shares_outstanding | 940,745,031 shares | valid 2026-10-26 to present | conf 0.95 | valid | [clm_ACF69B8AA825](/claim/clm_ACF69B8AA825.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/0000059478-26-000108-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | total_assets | 148,072,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_D20ADDDE60AB](/claim/clm_D20ADDDE60AB.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/0000059478-26-000108-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 40,271,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_82ACC132512E](/claim/clm_82ACC132512E.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947826000108/0000059478-26-000108-index.htm ## Ended (6) Held on 2025-11-08, not on 2026-11-08, and not replaced by another value. - [Eli Lilly and Company](/record/eli-lilly.md) | cash_and_equivalents | 9,791,900,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_AEB07A485FC9](/claim/clm_AEB07A485FC9.md) | [clm_599C7D287C29](/claim/clm_599C7D287C29.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 5,582,500,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_063460475B4C](/claim/clm_063460475B4C.md) | [clm_74B5C29B477B](/claim/clm_74B5C29B477B.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_revenue | 17,600,800,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_DF742A5515B7](/claim/clm_DF742A5515B7.md) | [clm_D3881089FBD6](/claim/clm_D3881089FBD6.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | shares_outstanding | 945,383,757 shares | valid 2025-10-27 to 2026-02-09 | conf 0.95 | superseded | superseded_by [clm_5A4FA78D8054](/claim/clm_5A4FA78D8054.md) | [clm_3242C5557E98](/claim/clm_3242C5557E98.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | total_assets | 114,935,400,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_C278ED944402](/claim/clm_C278ED944402.md) | [clm_C3E87E59336F](/claim/clm_C3E87E59336F.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm - [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 23,793,300,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_6628DA8282A8](/claim/clm_6628DA8282A8.md) | [clm_AA3E6D040F0E](/claim/clm_AA3E6D040F0E.md) sources: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm ## Unchanged 10 claims held on both days: cik 1, fiscal_year_end 1, headquarters 1, listed_on 1, quarterly_research_and_development 1, registrant_name 1, research_and_development 1, sic_industry 1, state_of_incorporation 1, ticker 1. ## Get this data - JSON: /v1/entities/eli-lilly/diff?from=2025-11-08&to=2026-11-08 - MCP: entity_diff(entity: "eli-lilly", from: "2025-11-08", to: "2026-11-08") - Entity twin: /record/eli-lilly.md · timeline: /timelines/eli-lilly.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.